These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22391106)

  • 1. Non-steroidal anti-inflammatory drugs and efficacy of antidepressants in major depressive disorder.
    Uher R; Carver S; Power RA; Mors O; Maier W; Rietschel M; Hauser J; Dernovsek MZ; Henigsberg N; Souery D; Placentino A; Farmer A; McGuffin P
    Psychol Med; 2012 Oct; 42(10):2027-35. PubMed ID: 22391106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder.
    Köhler-Forsberg O; Larsen ER; Buttenschøn HN; Rietschel M; Hauser J; Souery D; Maier W; Farmer A; McGuffin P; Aitchison KJ; Uher R; Mors O
    Br J Psychiatry; 2019 Aug; 215(2):494-501. PubMed ID: 30698114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
    Uher R; Tansey KE; Dew T; Maier W; Mors O; Hauser J; Dernovsek MZ; Henigsberg N; Souery D; Farmer A; McGuffin P
    Am J Psychiatry; 2014 Dec; 171(12):1278-86. PubMed ID: 25017001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of escitalopram and nortriptyline on painful symptoms in patients with major depression.
    Jaracz J; Gattner K; Moczko J; Hauser J
    Gen Hosp Psychiatry; 2015; 37(1):36-9. PubMed ID: 25480462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.
    Uher R; Mors O; Rietschel M; Rajewska-Rager A; Petrovic A; Zobel A; Henigsberg N; Mendlewicz J; Aitchison KJ; Farmer A; McGuffin P
    J Clin Psychiatry; 2011 Nov; 72(11):1478-84. PubMed ID: 22127194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in subjective and objective neurocognitive functions in patients with major depressive disorder: a 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study.
    Jeon HJ; Woo JM; Lee SH; Kim EJ; Chung S; Ha JH; Fava M; Mischoulon D; Kim JH; Heo JY; Yu BH
    J Clin Psychopharmacol; 2014 Apr; 34(2):218-25. PubMed ID: 24525660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic disposition to inflammation and response to antidepressants in major depressive disorder.
    Zwicker A; Fabbri C; Rietschel M; Hauser J; Mors O; Maier W; Zobel A; Farmer A; Aitchison KJ; McGuffin P; Lewis CM; Uher R
    J Psychiatr Res; 2018 Oct; 105():17-22. PubMed ID: 30130674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body weight as a predictor of antidepressant efficacy in the GENDEP project.
    Uher R; Mors O; Hauser J; Rietschel M; Maier W; Kozel D; Henigsberg N; Souery D; Placentino A; Perroud N; Dernovsek MZ; Strohmaier J; Larsen ER; Zobel A; Leszczynska-Rodziewicz A; Kalember P; Pedrini L; Linotte S; Gunasinghe C; Aitchison KJ; McGuffin P; Farmer A
    J Affect Disord; 2009 Nov; 118(1-3):147-54. PubMed ID: 19269691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association between polymorphisms of Val66Met in the BDNF gene and the response to escitalopram and nortriptyline treatment in the light of the neurodevelopmental hypothesis of depression].
    Rajewska-Rager A; Skibińska M; Szczepankiewicz A; Kapelski P; Dmitrzak-Weglarz M; Leszczyńska-Rodziewicz A; Hauser J
    Psychiatr Pol; 2008; 42(6):915-23. PubMed ID: 19441668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms.
    Uher R; Perlis RH; Henigsberg N; Zobel A; Rietschel M; Mors O; Hauser J; Dernovsek MZ; Souery D; Bajs M; Maier W; Aitchison KJ; Farmer A; McGuffin P
    Psychol Med; 2012 May; 42(5):967-80. PubMed ID: 21929846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression-Associated Gene
    Carboni L; Pischedda F; Piccoli G; Lauria M; Musazzi L; Popoli M; Mathé AA; Domenici E
    Cells; 2020 Jul; 9(8):. PubMed ID: 32751911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-random dropout and the relative efficacy of escitalopram and nortriptyline in treating major depressive disorder.
    Power RA; Muthén B; Henigsberg N; Mors O; Placentino A; Mendlewicz J; Maier W; McGuffin P; Lewis CM; Uher R
    J Psychiatr Res; 2012 Oct; 46(10):1333-8. PubMed ID: 22770672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
    Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM
    Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
    Azorin JM; Llorca PM; Despiegel N; Verpillat P
    Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association between polymorphisms of ins/del in the 5-HTT gene and T102C in the 5HTR2A gene and the drug response for escitalopram and nortriptyline in depressed patients].
    Rajewska-Rager A; Dmitrzak-Weglarz M; Kapelski P; Skibińska M; Kaczmarkiewicz-Fass M; Hauser J
    Psychiatr Pol; 2008; 42(6):903-14. PubMed ID: 19441667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.
    Strohmaier J; Wüst S; Uher R; Henigsberg N; Mors O; Hauser J; Souery D; Zobel A; Dernovsek MZ; Streit F; Schmäl C; Kozel D; Placentino A; Farmer A; McGuffin P; Aitchison KJ; Rietschel M
    World J Biol Psychiatry; 2011 Oct; 12(7):528-38. PubMed ID: 21388237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Major Adverse Cardiovascular Events Associated with Concomitant Use of Antidepressants and Non-steroidal Anti-inflammatory Drugs: A Retrospective Cohort Study.
    Jeong HE; Oh IS; Kim WJ; Shin JY
    CNS Drugs; 2020 Oct; 34(10):1063-1074. PubMed ID: 32737794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Risk of Peptic Ulcer Among Users of Antidepressants Combined With Nonsteroidal Anti-inflammatory Drugs.
    Shin JY; Song I; Lee JH; Yoon JL; Kwon JS; Park BJ
    J Clin Psychopharmacol; 2017 Apr; 37(2):239-245. PubMed ID: 28166082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in body weight during pharmacological treatment of depression.
    Uher R; Mors O; Hauser J; Rietschel M; Maier W; Kozel D; Henigsberg N; Souery D; Placentino A; Keers R; Gray JM; Dernovsek MZ; Strohmaier J; Larsen ER; Zobel A; Szczepankiewicz A; Kalember P; Mendlewicz J; Aitchison KJ; McGuffin P; Farmer A
    Int J Neuropsychopharmacol; 2011 Apr; 14(3):367-75. PubMed ID: 20716398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.